Lung Cancer Susceptibility 3 (LNCR3)

Lung Cancer Susceptibility 3, also known as lung adenocarcinoma, is related to lung cancer and mucinous lung adenocarcinoma. An important gene associated with Lung Cancer Susceptibility 3 is EGFR (Epidermal Growth Factor Receptor), and among its related pathways/superpathways are GPCR Pathway and Signaling by Receptor Tyrosine Kinases. The drugs Atezolizumab and Endostar protein have been mentioned in the context of this disorder. Affiliated tissues include lung and lymph node, and related phenotypes are normal and renal/urinary system